Regis Healthcare Ltd. (AU:REG)
ASX:REG
Want to see AU:REG full AI Analyst Report?
Top Page
Regis Healthcare Ltd.
(Sydney:REG)
Select Model
Select Model
Rating:56Neutral
Price Target:
AU$6.50
▲(10.36% Upside)
Action:Reiterated
Date:11/28/25
Regis Healthcare Ltd. demonstrates positive technical momentum and operational efficiency, contributing to a moderate overall score. However, financial risks due to high leverage and a high P/E ratio indicating potential overvaluation are significant concerns. The lack of earnings call data and corporate events limits further insights.
Positive Factors
Operating Cash Generation
Sustained strong operating cash flow versus net income indicates the core aged‑care operations convert revenue into cash reliably. Over 2–6 months this underpins funding for working capital, routine capex and service continuity without immediate reliance on new financing.
Negative Factors
High Financial Leverage
Negative equity and heavy leverage materially constrain financial flexibility. Over months this increases refinancing and covenant risk, limits ability to invest or weather funding changes, and heightens sensitivity to interest rates and cash flow volatility.
Read all positive and negative factors
Positive Factors
Negative Factors
Operating Cash Generation
Sustained strong operating cash flow versus net income indicates the core aged‑care operations convert revenue into cash reliably. Over 2–6 months this underpins funding for working capital, routine capex and service continuity without immediate reliance on new financing.
Read all positive factors
Regis Healthcare Ltd. (REG) vs. iShares MSCI Australia ETF (EWA)
Market Cap
AU$1.91B
Dividend Yield2.3%
Average Volume (3M)1.72M
Price to Earnings (P/E)49.2
Beta (1Y)0.92
Revenue Growth14.95%
EPS Growth151.90%
CountryAU
Employees11,000
SectorHealthcare
Sector Strength45
IndustryMedical - Care Facilities
Share Statistics
EPS (TTM)0.12
Shares Outstanding302,361,500
10 Day Avg. Volume1,078,239
30 Day Avg. Volume1,722,836
Financial Highlights & Ratios
PEG Ratio-0.15
Price to Book (P/B)-141.20
Price to Sales (P/S)2.05
P/FCF Ratio10.75
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
AU$8.20Price Target Upside39.22% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering3
EPS Forecast (FY)0.18
Revenue Forecast (FY)AU$1.39B
Regis Healthcare Ltd. Business Overview & Revenue Model
Company Description
Regis Healthcare Limited provides residential aged care services in Australia. The company offers home care services, including personal hygiene and care, dressing and undressing, mobility and transportation, rehabilitation, and others; and home h...
How the Company Makes Money
Regis Healthcare primarily makes money by providing residential aged care services in its facilities. Revenue is generated from (1) government funding associated with eligible residents’ care needs (typically the largest component of revenue in Au...
Regis Healthcare Ltd. Financial Statement Overview
Summary
Income Statement
65
Positive
Balance Sheet
40
Negative
Cash Flow
55
Neutral
| Breakdown | TTM | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 1.25B | 1.15B | 1.01B | 771.48M | 717.89M | 685.87M |
| Gross Profit | 139.90M | 141.46M | 47.17M | -3.78M | 5.18M | 67.54M |
| EBITDA | 169.58M | 240.44M | 191.45M | 96.81M | 55.86M | 82.65M |
| Net Income | 38.03M | 48.95M | -21.41M | -28.45M | -38.80M | 19.95M |
Balance Sheet | ||||||
| Total Assets | 2.60B | 2.11B | 1.81B | 1.71B | 1.76B | 1.75B |
| Cash, Cash Equivalents and Short-Term Investments | 197.97M | 192.47M | 64.91M | 61.32M | 4.15M | 3.89M |
| Total Debt | 7.99M | 5.11M | 3.84M | 71.07M | 113.32M | 153.41M |
| Total Liabilities | 2.63B | 2.12B | 1.84B | 1.67B | 1.68B | 1.61B |
| Stockholders Equity | -29.95M | -16.72M | -22.89M | 38.39M | 79.01M | 141.97M |
Cash Flow | ||||||
| Free Cash Flow | 233.44M | 219.64M | 186.57M | 53.73M | 67.60M | 87.75M |
| Operating Cash Flow | 389.26M | 306.11M | 252.30M | 105.16M | 114.79M | 105.03M |
| Investing Cash Flow | -320.67M | -132.74M | -136.59M | 6.58M | -48.62M | 7.50M |
| Financing Cash Flow | -50.54M | -45.81M | -112.12M | -43.17M | -62.39M | -119.47M |
Regis Healthcare Ltd. Technical Analysis
Negative
5.89
Price Trends
6.28
Negative
6.41
Negative
6.82
Negative
Market Momentum
0.02
Negative
46.73
Neutral
43.28
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AU:REG, the sentiment is Negative. The current price of 5.89 is below the 20-day moving average (MA) of 6.24, below the 50-day MA of 6.28, and below the 200-day MA of 6.82, indicating a bearish trend. The MACD of 0.02 indicates Negative momentum. The RSI at 46.73 is Neutral, neither overbought nor oversold. The STOCH value of 43.28 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for AU:REG.
Regis Healthcare Ltd. Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
64 Neutral | AU$8.36B | 28.87 | 5.75% | 2.25% | 8.65% | 3233.99% | |
59 Neutral | AU$380.67M | 15.02 | 16.35% | 4.60% | 1.12% | -12.02% | |
56 Neutral | AU$1.91B | 49.19 | -162.99% | 2.30% | 14.95% | 151.90% | |
55 Neutral | AU$768.08M | 53.67 | 2.05% | 2.65% | 56.28% | 55.14% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
45 Neutral | AU$60.15M | -0.49 | -131.13% | ― | 2086.71% | -116.20% |
* Healthcare Sector Average
AU:REG
Regis Healthcare Ltd.
6.20
-1.23
-16.57%
AU:RHC
Ramsay Health Care
36.07
-1.12
-3.00%
AU:IDX
Integral Diagnostics Ltd.
2.03
-0.25
-10.81%
AU:ACL
Australian Clinical Labs Ltd
2.04
-0.61
-22.87%
AU:BOT
Botanix Pharmaceuticals Limited
0.02
-0.30
-93.12%
Regis Healthcare Ltd. Corporate Events
Regis Director Trims Indirect Stake to Cover Personal Tax Obligations
May 7, 2026
Regis Healthcare has disclosed a change in the shareholding of director Linda Jane Mellors, who holds an indirect interest in the company through the Davies and Mellors Family Trust. The filing outlines her role as director of the trustee company ...
Regis Healthcare appoints Andrew Kinkade as new CEO to drive growth and transformation
Apr 28, 2026
Regis Healthcare has announced the appointment of Andrew Kinkade as its new Managing Director and Chief Executive Officer, effective 20 July 2026, succeeding Dr Linda Mellors. Kinkade brings more than two decades of experience across aged care, he...
Regis Healthcare Cancels 125,816 Unvested Performance Rights
Mar 11, 2026
Regis Healthcare Limited has notified the market that 125,816 performance rights, classified under ASX security code REGAA, have lapsed. The lapse occurred because the conditions attached to these conditional rights were not met or could no longer...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.